Regeneron Pharmaceuticals, Inc.
NASDAQ:REGN
Overview | Financials
Company Name | Regeneron Pharmaceuticals, Inc. |
Symbol | REGN |
Currency | USD |
Price | 804.33 |
Market Cap | 86,925,551,760 |
Dividend Yield | 0% |
52-week-range | 784.96 - 1,211.2 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Leonard S. Schleifer M.D., Ph.D. |
Website | https://www.regeneron.com |
An error occurred while fetching data.
About Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein occlusion, including macular edema following
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD